Clinical Trials on Scaphoid-Lunate Instability

Total 987 results

Barts & The London NHS Trust
Harvard Medical School (HMS and HSDM); Brigham and Women's Hospital

Unknown

Neurosurgical Transitional Care Programme (TCP)

Brain Diseases | Spinal Diseases | Brain Cancer | Brain Tumor | Surgery | Spinal Stenosis | Aneurysm | Fusion of Spine | Brain Metastases | Spinal Fusion | Trigeminal Neuralgia | Brain Tumor, Recurrent | Hydrocephalus | Spinal Cord Neoplasms | Brain Lesion | SPINAL Fracture | Brain Pathology | Spinal Instability | Spinal Curvature | Chiari; Net and other conditions

United Kingdom
Jip Groen
InBiome

Recruiting

Molecular Culture for the Diagnosis of Neonatal Sepsis

Microbial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal Sepsis

Netherlands
Centre for Addiction and Mental Health
National Institute of Mental Health (NIMH)

Active, not recruiting

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT) (ONR)

Depression | Dementia | Mild Cognitive Impairment | Major Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric Depression

United States, Canada
Amicus Therapeutics

Completed

Gene Therapy for Children With Variant Late Infantile Neuronal Ceroid Lipofuscinosis 6 (vLINCL6) Disease

Variant Late-Infantile Neuronal Ceroid Lipofuscinosis

United States
Region Stockholm
Rigshospitalet, Denmark

Recruiting

Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy (LiBRA)

Cognitive Impairment | Brain Tumor | Cognitive Decline | Memory Impairment | Radiotherapy Side Effect | Radiotherapy; Complications | Late Effect of Radiation

Sweden
Ewha Womans University Seoul Hospital
Ewha Womans University Mokdong Hospital; National Rehabilitation Center, Seoul...

Not yet recruiting

The Effectiveness of Smartphone-Based Speech Therapy for People With Post-Stroke Dysarthria

Dysarthria as Late Effect of Stroke
Taiwan Adventist Hospital

Completed

Investigating Program of Food Preparation on Diet Improvement for Patients With Stroke

Stroke | Dysphagia, Late Effect of Stroke

Taiwan
University College Dublin
Wellcome Trust; Health Research Board, Ireland; National Maternity Hospital,... and other collaborators

Recruiting

Markers of Platelet Activation foR Identification of Late Onset Sepsis in Preterm Infants (PARENT)

Late-Onset Neonatal Sepsis | Necrotising Enterocolitis | Culture Negative Neonatal Sepsis

Ireland
Ohio State University
University of South Florida; New York University; National Institute on Minority... and other collaborators

Active, not recruiting

Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women (A-RCT)

Depression | Anxiety | Emotional Disturbances | Nutritional Deficiency | Pregnancy Late | Post-Partum Depression

United States
BioMarin Pharmaceutical

Active, not recruiting

Cerliponase Alfa Observational Study in the US

Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2

United States
Per Torp Sangild

Completed

Bovine Colostrum as a Human Milk Fortifier for Preterm Infants (FortiColos-Ⅱ)

Necrotizing Enterocolitis | Feeding Intolerance | Postnatal Growth | Late-Onset Neonatal Sepsis

China
Weill Medical College of Cornell University
National Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaborators

Completed

Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis

Batten Disease | Late Infantile Neuronal Ceroid Lipofuscinosis

United States
Imperial College London
Chelsea and Westminster NHS Foundation Trust; National Heart and Lung Institute and other collaborators

Completed

Defining the Intestinal Microbiota in Premature Neonates

Necrotizing Enterocolitis | Premature Intestinal Microbiota | Late Onset Bloodstream Infection

United Kingdom
Weill Medical College of Cornell University

Terminated

Collection of Cerebrospinal Fluid in Healthy Children

Batten Disease | Late Infantile Neuronal Ceroid Lipofuscinosis

United States
Weill Medical College of Cornell University
Nathan's Battle Foundation

Completed

Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis

Batten Disease | Late Infantile Neuronal Ceroid Lipofuscinosis

United States
University of Nottingham
National Institute for Health Research, United Kingdom; International Stem...

Completed

Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors

Quality of Life | Cancer | Hearing Loss, Sensorineural | Tinnitus, Subjective | Late Effect

United Kingdom
University of Southern California
National Institute on Aging (NIA); Northern California Institute of Research... and other collaborators

Completed

Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)

Mild Cognitive Impairment (MCI) | Alzheimer's Disease (AD) | Significant Memory Concern (SMC) | Early Mild Cognitive Impairment (EMCI) | Late Mild Cognitive Impairment (LMCI)

United States, Canada
Weill Medical College of Cornell University
National Institutes of Health (NIH)

Completed

Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)

Batten Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis

United States
Weill Medical College of Cornell University

Completed

AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis

Batten Disease | Late Infantile Neuronal Ceroid Lipofuscinosis

United States
Ain Shams University

Completed

Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial

Feeding; Difficult, Newborn | Necrotizing Enterocolitis of Newborn | Late Onset Neonatal Sepsis

Egypt
IBSS Biomed S.A.
Ministry of Science and Higher Education, Poland

Completed

Effects of Oral Probiotic Supplementation on the Clinical Status of Very-low-birth-weight Preterm Neonates.

Necrotizing Enterocolitis | Infant, Very Low Birth Weight | Late Onset Neonatal Sepsis
Astellas Gene Therapies

Recruiting

A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease

Pompe Disease (Late-onset)

United States, Spain, France, Taiwan, Italy
Amicus Therapeutics

Completed

A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease (PROPEL)

Pompe Disease (Late-onset)

United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
Duke University

Completed

Pompe Gene Therapy- Screening for Eligibility

Pompe Disease (Late-onset)

United States
Amicus Therapeutics

Terminated

STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

Late-onset Pompe Disease

United States, Canada, Australia, Belgium
BioMarin Pharmaceutical

Terminated

BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)

Late-onset Pompe Disease

United States, United Kingdom, Germany, France, Italy, Portugal, Belgium, Netherlands
Common Sense

Unknown

Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery

Preterm Birth | Bacterial Vaginosis | Vaginal Infections | Preterm Premature Rupture of Membranes | Late Miscarriage

Israel
GeneCradle Inc

Recruiting

Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug

Pompe Disease (Late-onset)

China
Per Torp Sangild
Shenzhen People's Hospital; Sixth Affiliated Hospital, Sun Yat-sen University; Maternal and Child Health Hospital of Foshan and other collaborators

Completed

Bovine Colostrum for Preterm Newborns (PreColos-RCT)

Necrotizing Enterocolitis | Enteral Feeding Intolerance | Late-Onset Neonatal Sepsis

China
REGENXBIO Inc.

Withdrawn

A Retrospective, Natural History Study in Children With CLN2

Late-infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2)
BioMarin Pharmaceutical

Completed

A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease

Batten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease

United States, Italy, Germany, United Kingdom
Fundació Institut de Recerca de l'Hospital de la...
Genzyme, a Sanofi Company

Unknown

Search for Serum/Plasma Biomarkers in Pompe's Disease (BIOPOMPE)

Pompe Disease | Late Onset Pompe Disease

Spain
Rigshospitalet, Denmark
Copenhagen University Hospital - Rigshospitalet, Department of Occupational... and other collaborators

Recruiting

The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer (SaVe)

Cancer | Colorectal Cancer | Chemotherapy | Exercise | Sarcopenia | Vertigo | Rehabilitation | Elderly | Older Adults | Resistance Training | Geriatric | Chemotherapy-induced Peripheral Neuropathy | Vestibular Rehabilitation | Oncologic Complications | Comprehensive Geriatric Assessment | Frail | Postural Stability | Balance... and other conditions

Denmark
Huashan Hospital

Not yet recruiting

Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)

Pompe Disease (Late-onset)

China
Astellas Gene Therapies

Recruiting

Gene Transfer Study in Patients With Late Onset Pompe Disease (FORTIS)

Pompe Disease (Late-onset)

United States, United Kingdom
Amicus Therapeutics

Recruiting

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

Pompe Disease (Late-onset)

United States, Taiwan, Japan, Australia, Canada
Amicus Therapeutics

Active, not recruiting

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With LOPD

Pompe Disease (Late-onset)

United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
Duke University
Genzyme, a Sanofi Company

Active, not recruiting

Developing a Management Approach for Patients With "Late-Onset" Pompe Disease

Pompe Disease (Late-onset) | Pompe Disease | GAA Deficiency

United States
BioMarin Pharmaceutical

Terminated

A Study of Respiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD)

Late-onset Pompe Disease

United States, United Kingdom
Duke University

Withdrawn

Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease

Pompe Disease (Late-onset)

United States
St George's, University of London
MRC/UVRI and LSHTM Uganda Research Unit; MU-JHU CARE

Active, not recruiting

Serosurveillance Study of Maternally Derived Anti-GBS Antibody (ProGreSs)

Group B Streptococcus Carrier in Childbirth | Group B Streptococcal Infection, Late-Onset | Group B Streptococcal Infection, Early-Onset | Group B Streptococcus Neonatal Sepsis | Group B Strep Infection

Uganda
St George's, University of London
MRC/UVRI and LSHTM Uganda Research Unit; MU-JHU CARE

Completed

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital (PREPARE)

Group B Streptococcus Carrier in Childbirth | Group B Streptococcal Infection, Late-Onset | Group B Streptococcal Infection, Early-Onset | Group B Streptococcus Neonatal Sepsis | Group B Strep Infection

Uganda
Protecting Brains Saving Futures

Not yet recruiting

Protecting Brains and Saving Futures - the PBSF Protocol (PBSF)

Brain Injuries | Intraventricular Hemorrhage | Congenital Heart Disease | Hypoxic-Ischemic Encephalopathy | Newborn Morbidity | Inborn Errors of Metabolism | Extracorporeal Membrane Oxygenation Complication | Respiratory Complication | Hemodynamic Instability | Nosocomial Infection | Neonatal Seizure | Brain... and other conditions

Brazil
BioMarin Pharmaceutical

Completed

A Safety, Tolerability, and Efficacy Study of Intracerebroventricular BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease

Batten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 Disorder

United States, Germany, Italy, United Kingdom
BioMarin Pharmaceutical

Completed

An Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease

Batten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 Disorder

United States, Germany, Italy, United Kingdom
BioMarin Pharmaceutical

Terminated

A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease

Late-onset Pompe Patients Untreated or Treated With rhGAA

Spain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
Rigshospitalet, Denmark
Danish Research Center for Magnetic Resonance

Recruiting

Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases

Glycogen Storage Disease | Pompe Disease (Late-onset) | McArdle Disease

Denmark
Michael Morowitz
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

NICU Antibiotics and Outcomes Trial (NANO)

Microbial Colonization | Late-Onset Neonatal Sepsis | Necrotizing Enterocolitis of Newborn | Extreme Prematurity | Death; Neonatal | Early-Onset Neonatal Sepsis

United States, Canada
Shire

Terminated

Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD

Late Infantile Metachromatic Leukodystrophy

Denmark
Genzyme, a Sanofi Company

Completed

Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.

Pompe Disease Late-Onset | Glycogen Storage Disease Type II GSD II

United States

Clinical Trials on Scaphoid-Lunate Instability

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations